GlaxoSmithKline’s MS Drug Tests Put on Hold After Fraud Claim

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GSK has ‘paused’ a Phase I trial of an MS drug and fired its China R&D chief, Jingwu Zhang, after finding ‘manipulated’ data in a paper published in Nature Medicine in 2010 .

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC